SMS Lifesciences India receives EIR with VAI for Telangana facility

16 Jul 2025 Evaluate

SMS Lifesciences India has received establishment inspection report (EIR) with a voluntary action indicated (VAI) status from the U.S. Food and Drug Administration (USFDA) for its API manufacturing facility (Unit 1) located at Kazipally, Telangana, on July 15, 2025. The receipt of EIR reaffirms the company’s commitment to maintaining global quality standards and enables access to the regulated US market and other highly regulated global markets.

SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.

Haleos Labs Share Price

1224.15 -61.65 (-4.79%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×